States are reportedly trying to stop doctors from 'hoarding' potential coronavirus treatment drugs


You've probably heard about panic-buying in grocery stores, but it turns out some doctors are reportedly heading down the same path.
The New York Times reports that states like Idaho, Kentucky, Ohio, Nevada, Oklahoma, North Carolina, and Texas are so worried that doctors are stockpiling potential novel coronavirus treatment drugs for themselves that they're issuing emergency restrictions, or at least guidelines, for pharmacists.
"This is a real issue and it is not some product of a few isolated bad apples," said Jay Campbell, the executive director of the North Carolina Board of Pharmacy. The fear is that doctors may be able to hoard treatment drugs for themselves and their families, while they become increasingly difficult to procure among the general public.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Many of the drugs have yet to be proven effective against COVID-19, but they are approved to treat malaria, lupus, rheumatoid arthritis, H.I.V., and other conditions, so states are concerned there could be a shortage for patients who need their prescriptions to be filled while dealing with those illnesses.
Idaho was the earliest state to jump on the problem, issuing a temporary rule banning pharmacies from dispensing chloroquine and hydrochloroquine unless the prescription includes a written diagnosis of a condition the drugs are proven to treat, which currently does not include COVID-19. Others have followed suit. Companies like CVS and Walgreens have said their pharmacists will comply with state rules and, in CVS' case, otherwise use "professional judgment" to determine a prescription's validity. Read more at The New York Times.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Nepal chooses toddler as its new ‘living goddess’
Under the Radar Girls between two and four are typically chosen to live inside the temple as the Kumari – until puberty strikes
-
October 5 editorial cartoons
Cartoons Sunday's political cartoons include half-truth hucksters, Capitol lockdown, and more
-
Jaguar Land Rover’s cyber bailout
Talking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts